Redwood Pharma to present at BioStock Investor Meeting in Stockholm on 14th of Sep. 2022
Redwood Pharma will participate in the BioStock Investor Meeting in Stockholm. CEO Martin Vidaeus will update the market about i.e. developments regarding its products in development including the medical device RP501 which is nearing market clearance/approval. To join the presentation in person, please register at the following link: https://www.biostock.se/biostockinvestormeeting/ The number of slots are limited and pre-registration is required – register now to secure your spot! The presentation inlcuding a question and answers period will be live-streamed